| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $49.1M | +9.9% |
| Cost of Revenue | $24.9M | -0.5% |
| Gross Profit | $24.2M | +23.2% |
| R&D Expense | $2.5M | +4.0% |
| SG&A Expense | $20.4M | +4.5% |
| Operating Income | $2.5M | +425.0% |
| Pre-tax Income | $1.3M | +136.7% |
| Income Tax | $83K | -26.8% |
| Net Income | $1.3M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.2M | +100.4% |
| Accounts Receivable | $7.2M | +4.5% |
| Current Assets | $20.0M | +36.1% |
| Total Assets | $46.1M | +10.2% |
| Current Liabilities | $25.5M | +42.8% |
| Total Liabilities | $32.2M | +6.7% |
| Stockholders' Equity | $13.9M | +19.1% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.0M | +97.8% |
| Capital Expenditures | $19K | -73.1% |
| Investing Cash Flow | -$19K | +99.8% |
| Financing Cash Flow | -$878K | +3.1% |
| Free Cash Flow | $7.0M | +101.3% |
| +133.4% |
| EPS (Basic) | $0.04 | +130.8% |
| EPS (Diluted) | $0.04 | +130.8% |